Bristol-Myers Squibb Company
Last updated September 27, 2026
Organization details
- Legal name
- Bristol-Myers Squibb Company
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Princeton
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BMY
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000014272
- EIN
- 22-0790350
Board of directors
-
Christopher S. Boerner · Director · Chief Executive OfficerSince 2024
-
Deepak Bhatt · DirectorSince 2023
-
Derica W. Rice · DirectorSince 2023
-
Gerald L. Storch · DirectorSince 2023
-
Giovanni Caforio · Director · Executive Chair of the BoardSince 2023
-
Julia A. Haller · DirectorSince 2023
-
Karen H. Vousden · DirectorSince 2023
-
Medina Manuel Hidalgo · DirectorSince 2023
-
Michael R. McMullen · DirectorSince 2024
-
Paula A. Price · DirectorSince 2023
-
Peter J. Arduini · DirectorSince 2023
-
Phyllis R. Yale · DirectorSince 2023
-
Theodore R. Samuels II · DirectorSince 2023
Chief executives
Christopher S. Boerner
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.2%
-
96.9%
-
96.9%
-
97.2%
-
98.1%
-
98.5%
-
98.9%
-
99.0%
-
99.5%
Board connections
11 of this board's directors also sit on 17 other boards.
- via Paula A. Price
- via Michael R. McMullen
- via Theodore R. Samuels II
- via Christopher S. Boerner
- via Phyllis R. Yale
- via Karen H. Vousden
- via Peter J. Arduini
- via Medina Manuel Hidalgo
- via Theodore R. Samuels II
- via Michael R. McMullen
- via Paula A. Price
- via Julia A. Haller
- via Giovanni Caforio
- via Derica W. Rice
- via Derica W. Rice
- via Derica W. Rice
- via Paula A. Price
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,287,264
- 4 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Massacesi Cristian Officer (EVP,Chief Med Offr,Head of Dev) | Open-market sale | −6,249 | $64.57 | $403,498 |
| Sep 1, 2026 | Short Bartie Wendy Officer (EVP, Corporate Affairs) | Option exercise | +1,236 | $66.92 | $82,713 |
| Sep 1, 2026 | Short Bartie Wendy Officer (EVP, Corporate Affairs) | Shares withheld for tax | −633 | $66.92 | $42,360 |
| Aug 25, 2026 | Holzer Phil M Officer (SVP and Controller) | Open-market sale | −500 | $67.50 | $33,750 |
| Aug 1, 2026 | Gallman Cari Officer (EVP, General Counsel) | Option exercise | +1,061 | — | — |
| Aug 1, 2026 | Massacesi Cristian Officer (EVP,Chief Med Offr,Head of Dev) | Option exercise | +51,172 | — | — |
| Aug 1, 2026 | Gallman Cari Officer (EVP, General Counsel) | Shares withheld for tax | −543 | $65.31 | $35,463 |
| Aug 1, 2026 | Massacesi Cristian Officer (EVP,Chief Med Offr,Head of Dev) | Shares withheld for tax | −26,175 | $65.31 | $1,709,489 |
| Jun 15, 2026 | Julia A. Haller Director | Option exercise | +20,460 | $53.76 | $1,099,930 |
| Jun 3, 2026 | Short Bartie Wendy Officer (EVP, Corporate Affairs) | Option exercise | +8,040 | — | — |
| Jun 3, 2026 | Short Bartie Wendy Officer (EVP, Corporate Affairs) | Shares withheld for tax | −3,876 | $54.72 | $212,095 |
| May 1, 2026 | Lenkowsky Adam Officer (EVP, Chief Commercial Officer) | Option exercise | +1,373 | — | — |
| May 1, 2026 | Lenkowsky Adam Officer (EVP, Chief Commercial Officer) | Other | −203 | — | — |
| May 1, 2026 | Lenkowsky Adam Officer (EVP, Chief Commercial Officer) | Shares withheld for tax | −599 | $58.22 | $34,874 |
| Apr 1, 2026 | Shanahan Karin Officer (EVP, Chief Supply Chain & Ops) | Option exercise | +3,307 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.